Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
October 31, 2025

Get In Touch

Ophthalmic EDTA Solution Improves Visual Function In Early-Stage Cataract Patients: Study Ophthalmology

Ophthalmic EDTA Solution Improves Visual Function In Early-Stage Cataract Patients: Study

  • 02 July 2025
  • 3 months ago

Numerous White Retinal Lesions Following Cataract Surgery: JAMA Ophthalmology Clinical Challenge Ophthalmology

Numerous White Retinal Lesions Following Cataract Surgery: JAMA Ophthalmology Clinical Challenge

  • 02 July 2025
  • 3 months ago

Common HIV Drugs May Prevent Leading Cause Of Vision Loss, Study Finds Ophthalmology

Common HIV Drugs May Prevent Leading Cause Of Vision Loss, Study Finds

  • 02 July 2025
  • 3 months ago

For Asymptomatic Patients With Primary Angle-Closure Suspect, Simple Eye Examination May Predict Glaucoma Ophthalmology

For Asymptomatic Patients With Primary Angle-Closure Suspect, Simple Eye Examination May Predict Glaucoma

  • 02 July 2025
  • 3 months ago

FDA Approves Syfovre As First Treatment For Geographic Atrophy Ophthalmology

FDA Approves Syfovre As First Treatment For Geographic Atrophy

  • 02 July 2025
  • 3 months ago

SARS-CoV-2 Viral Genetic Material Presence In Aqueous Humor Of Asymptomatic Individuals: AJO Ophthalmology

SARS-CoV-2 Viral Genetic Material Presence In Aqueous Humor Of Asymptomatic Individuals: AJO

  • 02 July 2025
  • 3 months ago

Breakthrough Technology Offers Promising Treatment For Ischemic Retinopathy Ophthalmology

Breakthrough Technology Offers Promising Treatment For Ischemic Retinopathy

  • 02 July 2025
  • 3 months ago

Fenofibrate Cuts Diabetic Retinopathy Risk By 27%: LENS Trial Ophthalmology

Fenofibrate Cuts Diabetic Retinopathy Risk By 27%: LENS Trial

  • 02 July 2025
  • 3 months ago

Hearing Loss Serious Concern With Respect To Use Of Teprotumumab In Thyroid Eye Disease Ophthalmology

Hearing Loss Serious Concern With Respect To Use Of Teprotumumab In Thyroid Eye Disease

  • 02 July 2025
  • 3 months ago

Lowest Dose Bevacizumab Effective For Retinopathy Of Prematurity: JAMA Ophthalmology

Lowest Dose Bevacizumab Effective For Retinopathy Of Prematurity: JAMA

  • 02 July 2025
  • 3 months ago

Recent News

12,678 PG medical seats under AIQ- MCC NEET PG cou...

  • 30 October, 2025

Merck Keytruda wins European Commission nod for lo...

  • 30 October, 2025

UP NEET 2025 round 3 allotment results postponed

  • 30 October, 2025

Achin Gupta to succeed Umang Vohra as Cipla MD, GC...

  • 30 October, 2025

Mumbai shocker: KEM Hospital doctor stabbed by col...

  • 30 October, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.